Christopher James Rose

Fagområder

Statistikk

Faglig bakgrunn

PhD i statistisk modellering av medisinske bildedata; postdoktorell forskning med utvikling av statistiske metoder for å evaluere effekten av nye legemidler (spesielt kreftbehandlinger); kommersiell erfaring med å jobbe med globale farmasøytiske selskaper.

Prosjekter og publikasjoner

Sykdomsbegrensende legemidler for behandling av primær-progressiv MS (PPMS), inkludert rituximab. En metodevurdering.

Unni Solveig Johansen Olsen, Maren Falch Lindberg, Eva Marie-Louise Denison, Christopher James Rose, Caryl Gay, Arild Aamodt, Jens Ivar Brox, Øystein Skare, Ove Furnes, Kathryn A Lee, Anners Lerdal, (2020). Predictors of chronic pain and level of physical function in total knee arthroplasty: a protocol for a systematic review and meta-analysis. BMJ Open s. 1-9. doi: 10.1136/bmjopen-2020-037674
Daniel Semakula, Allen Nsangi, Andrew David Oxman, Matt Oxman, Astrid Dahlgren, Sarah Ellen Rosenbaum, Angela Morelli, Claire Glenton, Simon Arnold Lewin, Laetitia Nyirazinyoye, Margaret Kaseje, Iain Chalmers, Atle Fretheim, Christopher James Rose, Nelson K. Sewankambo, (2020). Effects of the Informed Health Choices podcast on the ability of parents of primary school children in Uganda to assess the trustworthiness of claims about treatment effects: one-year follow up of a randomised trial. Trials doi: 10.1186/s13063-020-4093-x
Daniel Semakula, Allen Nsangi, Andrew David Oxman, Claire Glenton, Simon Arnold Lewin, Sarah Ellen Rosenbaum, Matt Oxman, Margaret Kaseje, Astrid Dahlgren, Christopher James Rose, Atle Fretheim, Nelson Sewankambo, (2019). Informed Health Choices media intervention for improving people's ability to critically appraise the trustworthiness of claims about treatment effects: A mixed-methods process evaluation of a randomised trial in Uganda. BMJ Open doi: 10.1136/bmjopen-2019-031510
Allen Nsangi, Daniel Semakula, Claire Glenton, Simon Arnold Lewin, Andrew David Oxman, Matt Oxman, Sarah Ellen Rosenbaum, Astrid Dahlgren, Laetitia Nyirazinyoye, Margaret Kaseje, Christopher James Rose, Atle Fretheim, Nelson K. Sewankambo, (2019). Informed health choices intervention to teach primary school children in low-income countries to assess claims about treatment effects: process evaluation. BMJ Open s. 1-13. doi: 10.1136/bmjopen-2019-030787

Jose Francisco Meneses Echavez, Asbjørn Steiro, Christopher James Rose, Hilde Tinderholt Myrhaug, Heid Nøkleby, Johan Siqveland, (2020). Education to improve labor market opportunities: a systematic review
Christopher James Rose, Unni Olsen, Maren Falch Lindberg, Eva Marie-Louise Denison, Arild Aamodt, Anners Lerdal, (2020). A new multivariate meta-analysis model for many variates and few studies
Ingrid Kristine Ohm, Torunn Elisabeth Tjelle, Christopher James Rose, Vida Hamidi, Gunhild Hagen, Atle Fretheim, (2020). Disease modifying drugs for treatment of primary progressive multiple sclerosis: A health technology assessment
Torunn Elisabeth Tjelle, Christopher James Rose, Ingrid Kristine Ohm, Eva Flovild Pike, Lise Lund Håheim, Julia Bidonde, Atle Fretheim, Lene Kristine Juvet, (2019). Disease-modifying treatments for relapsing remitting multiple sclerosis, including rituximab. A health technology assessment.

Gunhild Hagen, Hannisdahl Elisabeth, Christopher James Rose, Therese Kristine Dalsbø, (2020). Hvor effektive er legemidler til behandling av plakkpsoriasis?. Sykepleien Forskning doi: 10.4220/Sykepleienf.2020.81878

Kontakt

Telefon: 21 07 83 33

Besøksadresse

Sandakerveien 24c, Bygg D, 0473 Oslo

Vis i kart

Read in English

Christopher James Rose

Forsker, Ph.D C.Stat

Fagområder

Faglig bakgrunn

Prosjekter og publikasjoner

Prosjekter

Vitenskapelige artikler og bokkapitler

Rapporter og bøker

Andre

Kontakt

Besøksadresse